The FDA identified about 200 cases of this severe itching between 2017 and 2023. In most cases, the people affected had been using cetirizine or levocetirizine daily for three months or more, and ...

New medications coming soon: Here’s what’s been FDA approved in 2025 so far Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S.

FDA warns of severe itching risk when stopping long-term use of allergy medications cetirizine and levocetirizine, affecting quality of life for some users.

After a few delays, this rule went into effect on May 27, 2025. The FDA has not approved any Rx-to-OTC switches so far in 2025.